OB/GYN Clinical Alert – October 1, 2004
October 1, 2004
View Issues
-
Special Report: Cesareans for All?
It is clear that the United States Cesarean section rate (CSR), while tailing off in the late 1990s, is now again rapidly heading upward. What Should be the Ideal CSR? Why the Recent Rise in CSR? Whos Most Apt to Either Offer or Comply with Patient-Requested Cesarean Section? -
YKL-40 and Ovarian Cancer
YKL-40 may represent a novel marker for the detection of early-stage ovarian cancer. YKL-40 levels in early stage patients may also predict disease recurrence and survival. The use of YKL-40 in detection of early stage ovarian cancer deserves further investigation. -
Assessing Blood Estradiol Levels
Vihtamaki and colleagues from Finland measured the circulating levels of estradiol 12 hours after the topical, percutaneous, evening administration of 1.5 mg estradiol (EstroGel) in 10 women who had been using this method of hormone therapy for at least 2 years. -
Surgical Staging Of Ovarian Low Malignant Potential Tumors
Routine pelvic and para-aortic lymph node dissection is not necessary in the majority of women with ovarian low malignant potential tumors. -
Notice to Readers . . .
-
Pharmacology Watch: Linking COX-2 Inhibitors and Cardiovascular Event Risk
Viagra: Maximum Capacity at High-Altitudes?; FDA Actions. -
Clinical Briefs in Primary Care supplement